VALORANT player profile · Europe region · Account level 161 · Title “Disciplined” · 0 profile views
Current rank: ASCENDANT 3 - 17 RR (as of last recorded competitive match, 2026-06-03).
Peak recorded rank: IMMORTAL 1 - 64 RR (reached 2026-05-29).
Ranks derive from recorded ranked matches; games played while untracked may not be reflected.
| Tracked matches | 137 |
|---|---|
| Win rate | 37.5% (6 W / 10 L over 16 matches with recorded stats) |
| K/D | 1.02 (255 kills / 250 deaths / 58 assists) |
| Average combat score | 221 |
| Headshot rate | 36.7% |
| Date | Mode | Map | Agent | Result | K/D/A | ACS | RR |
|---|---|---|---|---|---|---|---|
| 2026-07-11 | Competitive | Summit | Waylay | L | 12/17/2 | 178 | - |
| 2026-07-09 | Competitive | Ascent | Clove | L | 15/18/3 | 244 | - |
| 2026-07-07 | Competitive | Haven | Clove | L | 19/18/8 | 212 | - |
| 2026-07-06 | Competitive | Summit | Waylay | W | 9/15/2 | 132 | - |
| 2026-07-06 | Competitive | Split | Waylay | L | 21/21/6 | 226 | - |
| 2026-07-02 | Competitive | Split | Veto | L | 7/14/1 | 147 | - |
| 2026-06-26 | Competitive | Split | Reyna | W | 13/12/4 | 212 | - |
| 2026-06-24 | Competitive | Ascent | Clove | W | 25/14/8 | 348 | - |
| 2026-06-03 | Competitive | Ascent | - | - | - | - | +17 |
| 2026-06-02 | Competitive | Breeze | - | - | - | - | -19 |
| 2026-06-02 | Competitive | Breeze | - | - | - | - | -19 |
| 2026-06-01 | Competitive | Fracture | - | - | - | - | +18 |
| 2026-06-01 | Competitive | Lotus | - | - | - | - | -18 |
| 2026-06-01 | Competitive | Lotus | - | - | - | - | +16 |
| 2026-05-31 | Competitive | Pearl | - | - | - | - | -19 |
| 2026-05-31 | Competitive | Split | - | - | - | - | +18 |
| 2026-05-31 | Competitive | Fracture | - | - | - | - | +16 |
| 2026-05-31 | Competitive | Lotus | - | - | - | - | -19 |
| 2026-05-31 | Competitive | Pearl | - | - | - | - | -19 |
| 2026-05-31 | Competitive | Fracture | Reyna | L | 18/16/2 | 259 | -18 |
Showing 20 of 137 tracked matches. The interactive profile lists all of them.
No penalty records for this player.